63 related articles for article (PubMed ID: 23725179)
1. Diabetes mellitus increases the risk of bladder cancer: an updated meta-analysis.
Yang XQ; Xu C; Sun Y; Han RF
Asian Pac J Cancer Prev; 2013; 14(4):2583-9. PubMed ID: 23725179
[TBL] [Abstract][Full Text] [Related]
2. Diabetes mellitus and risk of thyroid cancer: a meta-analysis.
Yeo Y; Ma SH; Hwang Y; Horn-Ross PL; Hsing A; Lee KE; Park YJ; Park DJ; Yoo KY; Park SK
PLoS One; 2014; 9(6):e98135. PubMed ID: 24927125
[TBL] [Abstract][Full Text] [Related]
3. Diabetes mellitus and the risk of ovarian cancer: a systematic review and meta-analysis of cohort and case-control studies.
Wang L; Zhong L; Xu B; Chen M; Huang H
BMJ Open; 2020 Dec; 10(12):e040137. PubMed ID: 33376163
[TBL] [Abstract][Full Text] [Related]
4. Diabetes mellitus increases the risk of bladder cancer: an updated meta-analysis of observational studies.
Fang H; Yao B; Yan Y; Xu H; Liu Y; Tang H; Zhou J; Cao L; Wang W; Zhang J; Zhao L; Chen X; Zhang F; Zhao Y
Diabetes Technol Ther; 2013 Nov; 15(11):914-22. PubMed ID: 24180357
[TBL] [Abstract][Full Text] [Related]
5. Association between metabolic syndrome, obesity, diabetes mellitus and oncological outcomes of bladder cancer: a systematic review.
Cantiello F; Cicione A; Salonia A; Autorino R; De Nunzio C; Briganti A; Gandaglia G; Dell'Oglio P; Capogrosso P; Damiano R
Int J Urol; 2015 Jan; 22(1):22-32. PubMed ID: 25345683
[TBL] [Abstract][Full Text] [Related]
6. Diabetes mellitus and the risk of bladder cancer: an Italian case–control study.
Turati F; Polesel J; Di Maso M; Montella M; Libra M; Grimaldi M; Tavani A; Serraino D; La Vecchia C; Bosetti C
Br J Cancer; 2015 Jun; 113(1):127-30. PubMed ID: 25996204
[TBL] [Abstract][Full Text] [Related]
7. Risk of bladder cancer in patients with diabetes mellitus: an updated meta-analysis of 36 observational studies.
Zhu Z; Wang X; Shen Z; Lu Y; Zhong S; Xu C
BMC Cancer; 2013 Jun; 13():310. PubMed ID: 23803148
[TBL] [Abstract][Full Text] [Related]
8. SGLT-2 Inhibitors in Cancer Treatment-Mechanisms of Action and Emerging New Perspectives.
Dutka M; Bobiński R; Francuz T; Garczorz W; Zimmer K; Ilczak T; Ćwiertnia M; Hajduga MB
Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497303
[TBL] [Abstract][Full Text] [Related]
9. Association of metabolic syndrome and the risk of bladder cancer: A prospective cohort study.
Fang S; Liu Y; Dai H; Gao T; Zeng L; Sun R; Zheng Z; Yuan J; Xia B; Pan Y
Front Oncol; 2022; 12():996440. PubMed ID: 36263231
[TBL] [Abstract][Full Text] [Related]
10. Is metabolic syndrome associated with high tumor grade and stage of bladder cancer: a systematic review and meta-analysis.
Feng D; Song P; Yang Y; Wei W; Li L
Transl Cancer Res; 2021 May; 10(5):2188-2198. PubMed ID: 35116537
[TBL] [Abstract][Full Text] [Related]
11. The Sirenic Links between Diabetes, Obesity, and Bladder Cancer.
Gill E; Sandhu G; Ward DG; Perks CM; Bryan RT
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681810
[TBL] [Abstract][Full Text] [Related]
12. Dysplastic urothelial changes accompany empagliflozin administration in urinary bladder of experimental diabetes.
Abdel-Hamid AAM; Firgany AEL
Int J Exp Pathol; 2019 Oct; 100(5-6):369-377. PubMed ID: 32040227
[TBL] [Abstract][Full Text] [Related]
13. Pre-existing type 2 diabetes is an adverse prognostic factor in patients with renal cell carcinoma.
Yang H; Yin K; Wang Y; Xia M; Zhang R; Wang W; Chen J; Wang C; Shuang W
J Diabetes; 2019 Dec; 11(12):993-1001. PubMed ID: 31141620
[TBL] [Abstract][Full Text] [Related]
14. Incidence of bladder cancer in Benghazi, Libya over the past three decades.
Saheb Sharif-Askari N; Bendardaf R; Saheb Sharif-Askari F; El Tabbal AM; El Ayan MA
Sci Rep; 2018 Jul; 8(1):10822. PubMed ID: 30018344
[TBL] [Abstract][Full Text] [Related]
15. Diabetes mellitus and the risk of bladder cancer: A PRISMA-compliant meta-analysis of cohort studies.
Xu Y; Huo R; Chen X; Yu X
Medicine (Baltimore); 2017 Nov; 96(46):e8588. PubMed ID: 29145273
[TBL] [Abstract][Full Text] [Related]
16. Differences in risk factors of malignancy between men and women with type 2 diabetes: A retrospective case-control study.
Dąbrowski M; Szymańska-Garbacz E; Miszczyszyn Z; Dereziński T; Czupryniak L
Oncotarget; 2017 Sep; 8(40):66940-66950. PubMed ID: 28978007
[TBL] [Abstract][Full Text] [Related]
17. Diabetes as a risk factor of hospitalization in the surgical ward due to cancer in the elderly and middle-aged population.
Dąbrowski M; Grondecka A
Arch Med Sci; 2017 Aug; 13(5):1025-1030. PubMed ID: 28883842
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for cancer development in type 2 diabetes: A retrospective case-control study.
Dąbrowski M; Szymańska-Garbacz E; Miszczyszyn Z; Dereziński T; Czupryniak L
BMC Cancer; 2016 Oct; 16(1):785. PubMed ID: 27724912
[TBL] [Abstract][Full Text] [Related]
19. The evaluation of the association between the metabolic syndrome and tumor grade and stage of bladder cancer in a Chinese population.
Sha N; Xu H; Chen T; Tian DW; Xie WQ; Xie LG; Zhang Y; Xing C; Liu XT; Shen ZH; Wu ZL; Hu HL; Wu CL
Onco Targets Ther; 2016; 9():1175-9. PubMed ID: 27022277
[TBL] [Abstract][Full Text] [Related]
20. A Review on the Relationship between SGLT2 Inhibitors and Cancer.
Lin HW; Tseng CH
Int J Endocrinol; 2014; 2014():719578. PubMed ID: 25254045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
